alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2
**Certification of Principal Financial Officer**
I, Patrick H. Dudasik, certify that:
1.  I have reviewed this Quarterly Report on Form 10-Q of Calamos Asset Management, Inc.; 2.  Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report; 3.  Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, and for,the periods presented in this report; 4.  The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this report is being prepared;
(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and
(c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and
5.  The registrant’s other certifying officer and I have disclosed, basedon our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of theregistrant’s board of directors (or persons performing the equivalentfunctions):
(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.
May 12, 2005   /S/ Patrick H. Dudasik  Patrick H. Dudasik  Executive Vice President, Chief Financial Officer  and Treasurer
Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Hangman  Productions,  Inc. (the
"Registrant")  on Form 10-Q for the quarter ending March 31, 2008, as filed with
the  Securities  and  Exchange  Commission  on the date hereof  (the  "Quarterly
Report"),  we, James Doolin and Shane  Thueson,  certify,  pursuant to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that:

     (1) The Quarterly  Report fully complies with the  requirements  of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) The information  contained in the Quarterly Report fairly presents,  in
all material respects,  the financial  condition and result of operations of the
Registrant.


Date: 05/13/08                  /S/ JAMES DOOLIN
                                --------------------------------------------
                                James Doolin, President and Director

Date: 05/13/08                  /S/ SHANE THUESON
                                --------------------------------------------
                                Shane Thueson, Vice President and Director
Case 5:04-cv-00147-C Document 9 Filed 07/19/2004 Page 1 of 5
Case 5:04-cv-00147-C Document 9 Filed 07/19/2004 Page 2 of 5
Case 5:04-cv-00147-C Document 9 Filed 07/19/2004 Page 3 of 5
Case 5:04-cv-00147-C Document 9 Filed 07/19/2004 Page 4 of 5
Case 5:04-cv-00147-C Document 9 Filed 07/19/2004 Page 5 of 5
Case 3:03-cv-00761-P Document 45 Filed 04/29/04 Page 1 of 2 PageID 254
Case 3:03-cv-00761-P Document 45 Filed 04/29/04 Page 2 of 2 PageID 255
# C_2016335EN.01004802.xml

| 12.9.2016 | EN | Official Journal of the European Union | C 335/48 |
| --- | --- | --- | --- |

12.9.2016

EN

Official Journal of the European Union

C 335/48

---

Action brought on 21 July 2016 — Asna v EUIPO — Wings Software (ASNA WINGS)

(Case T-382/16)

(2016/C 335/64)

Language in which the application was lodged: Spanish

Parties

Parties

Applicant: Asna, Inc. (San Antonio, Texas, United States) (represented by: J. Devaureix and J.C. Erdozain López, lawyers)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Other party to the proceedings before the Board of Appeal: Wings Software BVBA (Heist-Op-den-Berg, Belgium)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Applicant: Applicant

Applicant:

Trade mark at issue: European Union word mark ‘ASNA WINGS’ — Application for registration No 11 388 352

Trade mark at issue:

Procedure before EUIPO: Opposition proceedings

Procedure before EUIPO

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 26 April 2016 in Case R 436/2015-5

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | declare the application admissible, together with all of the relevant documents and copies; |
| --- | --- |

—

declare the application admissible, together with all of the relevant documents and copies;

| — | declare the proposed evidence admissible; |
| --- | --- |

—

declare the proposed evidence admissible;

| — | annul and declare inapplicable the contested decision; |
| --- | --- |

—

annul and declare inapplicable the contested decision;

| — | order EUIPO to pay the costs. |
| --- | --- |

—

order EUIPO to pay the costs.

Pleas in law

Pleas in law

| — | Error as to the proof of use by the other party; |
| --- | --- |

—

Error as to the proof of use by the other party;

| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation No 207/2009.

---
Exhibit 12.2


Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of EXFO Inc., hereby certifies, that:





1.
The Annual Report of Form 20-F for the year ended August 31, 2011 of EXFO fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in this Annual Report fairly presents, in all material respects, the financial condition and results of operations of EXFO.








Date:  November 23, 2011










/s/Germain Lamonde


Germain Lamonde


Chairman of the Board,


President and Chief Executive Officer


(Principal Executive Officer)





The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Report or as separate disclosure document.
Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

J. Erik Fyrwald, Chairman and Chief Executive Officer of Nalco Holding Company (Nalco) and Bradley J. Bell, Executive Vice President and
Chief Financial Officer of Nalco, in conjunction with the filing of Nalcos 10-Q financial report (the Report) with the Securities and Exchange Commission, covering the calendar quarter ending March 31, 2010, hereby certify as
follows:



| | a. | The Report fully complies with the requirements of the Securities Exchange Act of 1934, and
| | -- | -------------------------------------------------------------------------------------------



| | b. | The information in the Report fairly presents, in all material respects, the financial condition and results of operations for Nalco.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------



/s/ J. ERIK FYRWALDJ. Erik Fyrwald Chairman
and Chief Executive Officer Date: April 28, 2010




/s/ BRADLEY J. BELLBradley J. Bell Executive
Vice President and Chief Financial Officer
Date: April 28, 2010




34
# C_2022073EN.01004501.xml

| 14.2.2022 | EN | Official Journal of the European Union | C 73/45 |
| --- | --- | --- | --- |

14.2.2022

EN

Official Journal of the European Union

C 73/45

---

Order of the General Court of 29 November 2021 — Advansa Manufacturing and Others v Commission

(Case T-741/20) (1)

(Action for annulment - State aid - Guidelines on certain State aid measures in the context of the system for greenhouse gas emission allowance trading post-2021 - Eligible sectors - Exclusion of the man-made fibres manufacturing sector - Lack of direct concern - Inadmissibility)

(2022/C 73/56)

Language of the case: English

Parties

Applicants: Advansa Manufacturing GmbH (Frankfurt am Main, Germany) and the 14 other applicants whose names are set out in an annex to the order (represented by: D. Haverbeke, L. Ruessmann and P. Sellar, lawyers)

Defendant: European Commission (represented by: A. Bouchagiar and G. Braga da Cruz, acting as Agents)

Re:

Application under Article 263 TFEU for the annulment in part of the Communication from the Commission of 25 September 2020 entitled ‘Guidelines on certain State aid measures in the context of the system for greenhouse gas emission allowance trading post-2021’ (OJ 2020 C 317, p. 5).

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | There is no longer any need to adjudicate on the application to intervene submitted by the EFTA Surveillance Authority. |
| --- | --- |

2.

There is no longer any need to adjudicate on the application to intervene submitted by the EFTA Surveillance Authority.

| 3. | Advansa Manufacturing GmbH and the other applicants whose names are set out in the annex shall bear their own costs and pay those incurred by the European Commission. |
| --- | --- |

3.

Advansa Manufacturing GmbH and the other applicants whose names are set out in the annex shall bear their own costs and pay those incurred by the European Commission.

| 4. | The EFTA Surveillance Authority shall bear the costs relating to its application to intervene. |
| --- | --- |

4.

The EFTA Surveillance Authority shall bear the costs relating to its application to intervene.

---

(1)  OJ C 79, 8.3.2021.

---
OVERSTREET WEALTH MANAGEMENT, Appellant/Petitioner(s), v. RS WESTSHORE, LLC INC., Appellee/Respondent(s).

CASE NO.: 2D19-0231

District Court of Appeal of Florida, Second District.

March 20, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
EXHIBIT
32: Rule 13a-14(b) Certification





Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of NexxNow, Inc. (the
“Company”) certifies that:




1.           The
Quarterly Report on Form 10-Q of the Company for the period  ended
June 30, 2008 (the “Report”) fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
and




2.           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.








August
      14, 2008
            /s/
      Paul
  RileyPaul
      Riley (Chief Executive Officer and Chief Financial
  Officer)
# C_2018166EN.01003001.xml

| 14.5.2018 | EN | Official Journal of the European Union | C 166/30 |
| --- | --- | --- | --- |

14.5.2018

EN

Official Journal of the European Union

C 166/30

---

Order of the General Court of 16 March 2018 — KiK Textilien und Non-Food v EUIPO — FF Group Romania (_kix)

(Case T-822/16) (1)

1

((EU trade mark - Opposition proceedings - Application for EU figurative mark _kix - Revocation of the contested decision - Action which has become devoid of purpose - No need to adjudicate - Articles 173(1) and (2) of the Rules of Procedure - Intervention by the other party to the proceedings before the Board of Appeal - Response lodged out of time))

(2018/C 166/39)

Language of the case: English

Parties

Parties

Applicant: KiK Textilien und Non-Food GmbH (Bönen, Germany) (represented by: S. Körber and L. Pechan, lawyers)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: K. Zajfert and A. Folliard-Monguiral, acting as Agents)

Defendant:

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: FF Group Romania SRL (Bucharest, Romania) (represented by: A. Cavescu, lawyer)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 6 September 2016 (Case R 2323/2015-4), relating to opposition proceedings between KiK Textilien und Non-Food and FF Group Romania.

Operative part of the order

Operative part of the order

| 1. | There is no longer any need to adjudicate on the action. |
| --- | --- |

1.

There is no longer any need to adjudicate on the action.

| 2. | The European Union Intellectual Property Office (EUIPO) shall bear its own costs and pay those incurred by KiK Textilien und Non-Food GmbH. |
| --- | --- |

2.

The European Union Intellectual Property Office (EUIPO) shall bear its own costs and pay those incurred by KiK Textilien und Non-Food GmbH.

| 3. | FF Group Romania shall bear its own costs. |
| --- | --- |

3.

FF Group Romania shall bear its own costs.

---

(1)  OJ C 22, 23.1.2017.

1

---
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 98 Introduced in Senate (IS)]

<DOC>

118th CONGRESS
  1st Session
S. RES. 98

  Declaring March 8, 2023, as ``National Emily Warner & Women Airline 
                             Pilots Day''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 8, 2023

 Mr. Hickenlooper (for himself and Mr. Bennet) submitted the following 
    resolution; which was referred to the Committee on the Judiciary

_______________________________________________________________________

                               RESOLUTION

 
  Declaring March 8, 2023, as ``National Emily Warner & Women Airline 
                             Pilots Day''.

Whereas Emily Howell Warner (referred to in this preamble as ``Emily Warner'') 
        of the State of Colorado is a celebrated female airline pilot with a 
        proud legacy of promoting gender equality in all professions;
Whereas, 50 years ago, Emily Warner shattered the glass ceiling of the airline 
        flight deck in the United States when she was hired by Frontier Airlines 
        to be the first modern female airline pilot, opening the sky for other 
        female airline pilots;
Whereas, in 1974, Emily Warner became the first female member of the Air Line 
        Pilots Association, International;
Whereas, in 1976, Emily Warner became first female airline captain in the United 
        States;
Whereas Emily Warner was a founding member of--

    (1) the Colorado Pilots Association;

    (2) the International Society of Women Airline Pilots; and

    (3) the Friends of the Granby/Grand County Airport;

Whereas the Frontier Airlines uniform worn by Emily Warner hangs in the 
        Smithsonian Air and Space Museum;
Whereas, in 1994, Emily Warner was honored by Colorado Legislature Resolution 
        94-29, entitled ``Honoring Captain Emily Warner of the Achievements in 
        Aviation History'';
Whereas Emily Warner has been inducted into the Women in Aviation International 
        Pioneer Hall of Fame, the National Women's Hall of Fame, the National 
        Aviation Hall of Fame, the Irish-American Hall of Fame, the Colorado 
        Women's Hall of Fame, and the Colorado Aviation Hall of Fame;
Whereas, in 2015, the Granby/Grand County Airport was renamed Emily Warner Field 
        to honor the many contributions of Emily Warner to aviation;
Whereas roughly 6 percent of airline pilots in the United States are women; and
Whereas honoring the legacy of Emily Warner of breaking barriers for women in 
        aviation requires continued dedication and commitments to ensuring 
        greater representation of women in the airline pilot workforce and in 
        all aviation careers: Now, therefore, be it
    Resolved, That the Senate does hereby declare March 8, 2023, as 
``National Emily Warner & Women Airline Pilots Day''.
                                 <all>
```
# C_2017046EN.01002401.xml

| 13.2.2017 | EN | Official Journal of the European Union | C 46/24 |
| --- | --- | --- | --- |

13.2.2017

EN

Official Journal of the European Union

C 46/24

---

Action brought on 14 December 2016 — HJ v EMA

(Case T-881/16)

(2017/C 046/27)

Language of the case: French

Parties

Parties

Applicant: HJ (London, United Kingdom) (represented by: L. Levi and A. Blot, lawyers)

Applicant:

Defendant: European Medicines Agency

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | order the defendant to pay the applicant the symbolic sum of EUR 1 by way of compensation for the non-material harm suffered; |
| --- | --- |

—

order the defendant to pay the applicant the symbolic sum of EUR 1 by way of compensation for the non-material harm suffered;

| — | order the defendant to withdraw the memorandum of 22 July 2015 and, consequently, the applicant’s response of 23 July 2015, from the applicant’s personal file; |
| --- | --- |

—

order the defendant to withdraw the memorandum of 22 July 2015 and, consequently, the applicant’s response of 23 July 2015, from the applicant’s personal file;

| — | so far as necessary, annul the decision of the Authority Empowered to Conclude Contracts (AECE) of 21 March 2016 rejecting the applicant’s claim for damages submitted on 26 November 2015 and annul the decision of the AECE dated 19 October 2016 rejecting the applicant’s complaint of 20 June 2016 against the abovementioned decision; |
| --- | --- |

—

so far as necessary, annul the decision of the Authority Empowered to Conclude Contracts (AECE) of 21 March 2016 rejecting the applicant’s claim for damages submitted on 26 November 2015 and annul the decision of the AECE dated 19 October 2016 rejecting the applicant’s complaint of 20 June 2016 against the abovementioned decision;

| — | order the defendant to pay all the costs. |
| --- | --- |

—

order the defendant to pay all the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on a single plea in law alleging that the conditions required for the European Union to be held non-contractually liable, namely that of the illegality of the allegedly wrongful conduct, actual harm and the existence of a causal link between the conduct and the harm alleged to have been suffered, are satisfied in the present case. According to the applicant, the documents in his personal file, which were made public and accessible to any member of staff of the European Medicines Agency for a period of time, were not processed fairly and lawfully but were processed for purposes other than those for which they were collected without that change in purpose having been expressly authorised by the applicant. The dissemination of that sensitive data consequently called into question the applicant’s integrity, causing him real and certain non-material harm. In the applicant’s opinion, that harm must be attributed in its entirety to the Agency’s wrongful conduct.

---
Norman BONCK v. STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY and Linda M. Crockem

NO. 2019-C-0148

Supreme Court of Louisiana.

March 18, 2019

Denied.

GUIDRY, J., recused.
Exhibit 15.1


Deloitte UK
 Hill House
 1 Little New Street
 London
 EC4A 3TR
 
 Tel: +44(0)20 793 63000
 www.deloitte.co.uk
 
 
 
 
 Consent of Independent Registered Public Accounting Firm
 
 
 We consent to the incorporation by reference in Registration Statement Numbers: 333-74703, 333-81400, 333-84044, 333-127660, 333-128619, 333-128621, 333-140798, 333-145751, and 333-149577 on Form S-8 of our report dated 30 April 2015, relating to the 2014 and 2013 consolidated financial statements of RBS Holdings N.V. appearing in this Annual Report on Form 20-F of RBS Holdings N.V. for the year ended December 31, 2014.
 
 
 
 /s/Deloitte LLP
 London, United Kingdom
 
 30 April 2015
# C_2019305EN.01000801.xml

| 9.9.2019 | EN | Official Journal of the European Union | C 305/8 |
| --- | --- | --- | --- |

9.9.2019

EN

Official Journal of the European Union

C 305/8

---

Judgment of the Court (Fourth Chamber) of 3 July 2019 — Viridis Pharmaceutical Ltd. v European Union Intellectual Property Office (EUIPO), Hecht-Pharma GmbH

(Case C-668/17 P) (1)

(Appeal - European Union trade mark - Revocation proceedings - Word mark Boswelan - No genuine use - Use of the mark in a clinical trial prior to filing an application for authorisation to place a medicinal product on the market - Proper reason for non-use - Concept)

(2019/C 305/09)

Language of the case: German

Parties

Appellant: Viridis Pharmaceutical Ltd. (represented by C. Spintig, S. Pietzcker and M. Prasse, Rechtsanwälte)

Other parties to the proceedings: European Union Intellectual Property Office (EUIPO) (represented by S. Hanne, acting as Agent), Hecht-Pharma GmbH (represented by J. Sachs and C. Sachs, Rechtsanwälte)

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Viridis Pharmaceutical Ltd to pay, in addition to its own costs, those incurred by the European Union Intellectual Property Office (EUIPO) and Hecht-Pharma GmbH. |
| --- | --- |

2.

Orders Viridis Pharmaceutical Ltd to pay, in addition to its own costs, those incurred by the European Union Intellectual Property Office (EUIPO) and Hecht-Pharma GmbH.

---

(1)  OJ C 83, 5.3.2018.

---
EXHIBIT 13.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 20-F of Tata Communications Limited, a
limited liability company incorporated in the Republic of India (the Company) for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the
undersigned officers of the Company certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to such officers best knowledge, that:

1. the Report fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of
the Company as of, and for, the periods presented in the report.

The foregoing certification is provided solely for purposes of complying
with the provisions of Section 906 of the Sarbanes-Oxley Act of 2002 and is not intended to be used or relied upon for any other purpose.

Date: July 31, 2013



/s/ Vinod KumarVinod KumarManaging Director and Group CEO/s/ Sanjay BawejaSanjay BawejaChief Financial Officer